We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $412M
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
-4.98%
1 Year Est. Return
+28.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$215M
AUM Growth
+$104M
Cap. Flow
+$114M
Cap. Flow %
52.89%
Top 10 Hldgs %
3.25%
Holding
1,960
New
575
Increased
592
Reduced
190
Closed
602

Top Buys

Rank Stock Value
1
PLAB icon
Photronics
PLAB
+$919K
2
ALXO icon
ALX Oncology
ALXO
+$905K
3
EYPT icon
EyePoint Inc
EYPT
+$814K
4
MGNX icon
MacroGenics
MGNX
+$773K
5
CMPS
Compass Pathways
CMPS
+$725K

Top Sells

Rank Stock Value
1
STRO icon
Sutro Biopharma
STRO
+$394K
2
RIOT icon
Riot Platforms
RIOT
+$366K
3
REVG
REV Group
REVG
+$362K
4
TSHA icon
Taysha Gene Therapies
TSHA
+$353K
5
PBYI icon
Puma Biotechnology
PBYI
+$329K

Sector Composition

Rank Sector Weight
1 Healthcare 18.55%
2 Technology 15.83%
3 Industrials 15.4%
4 Financials 12.94%
5 Consumer Discretionary 11.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLAB icon
1
Photronics
PLAB
$1.66B
$941K 0.44%
38,160
+33,877
+791% +$919K
FN icon
2
Fabrinet
FN
$14.2B
$801K 0.37%
3,272
+2,733
+507% +$580K
UNF icon
3
Unifirst Corp
UNF
$4.97B
$734K 0.34%
4,278
+3,320
+347% +$535K
KWR icon
4
Quaker Houghton
KWR
$2.76B
$719K 0.33%
4,239
+3,654
+625% +$675K
PRO
5
DELISTED
PROS Holdings
PRO
$652K 0.3%
+22,773
New +$723K
MTW icon
6
Manitowoc
MTW
$737M
$640K 0.3%
55,468
+47,427
+590% +$586K
BOC icon
7
Boston Omaha
BOC
$416M
$632K 0.29%
46,930
+31,919
+213% +$472K
TDY icon
8
Teledyne Technologies
TDY
$28.2B
$629K 0.29%
1,620
+1,290
+391% +$511K
NVDA icon
9
NVIDIA
NVDA
$5.52T
$628K 0.29%
5,081
+3,041
+149% +$307K
MTRX icon
10
Matrix Service
MTRX
$297M
$626K 0.29%
63,022
+51,588
+451% +$590K
JNJ icon
11
Johnson & Johnson
JNJ
$671B
$622K 0.29%
4,258
+2,117
+99% +$315K
TGLS icon
12
Tecnoglass Holdings
TGLS
$1.74B
$606K 0.28%
12,082
+7,727
+177% +$403K
ALNT icon
13
Allient
ALNT
$1.53B
$586K 0.27%
23,191
+21,219
+1,076% +$608K
SSNC icon
14
SS&C Technologies
SSNC
$19.9B
$562K 0.26%
8,971
+5,254
+141% +$326K
CMPS
15
Compass Pathways
CMPS
$1.84B
$556K 0.26%
+92,130
New +$725K
CTKB icon
16
Cytek Biosciences
CTKB
$611M
$553K 0.26%
+99,036
New +$595K
TTEC icon
17
TTEC Holdings
TTEC
$68M
$539K 0.25%
91,705
+83,244
+984% +$610K
LASR icon
18
nLIGHT
LASR
$2.39B
$539K 0.25%
49,281
+28,578
+138% +$347K
VPG icon
19
Vishay Precision Group
VPG
$836M
$530K 0.25%
17,419
+13,308
+324% +$436K
ORGO icon
20
Organogenesis Holdings
ORGO
$211M
$530K 0.25%
+189,271
New +$508K
STAA icon
21
STAAR Surgical
STAA
$1.18B
$523K 0.24%
+10,993
New +$482K
NXDR
22
Nextdoor Holdings
NXDR
$870M
$523K 0.24%
188,096
+129,037
+218% +$298K
THR
23
DELISTED
Thermon Group Holdings
THR
$518K 0.24%
16,830
+10,499
+166% +$336K
BASE
24
DELISTED
Couchbase
BASE
$516K 0.24%
+28,278
New +$658K
ORIC icon
25
Oric Pharmaceuticals
ORIC
$1.32B
$514K 0.24%
+72,712
New +$651K
1
2 3 4 5

Similar funds

KP
Kiltearn Partners Edinburgh, United Kingdom $412M AUM 26.77% 1-Year Est. Return
T
TOBAM Paris, France $412M AUM 18.33% 1-Year Est. Return
HP
Hilltop Partners Mishawaka, Indiana $412M AUM 26.77% 1-Year Est. Return
WIP
WealthCare Investment Partners Portsmouth, Rhode Island $412M AUM 24.95% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $412M AUM 34.27% 1-Year Est. Return
AWP
Accretive Wealth Partners Parsippany, New Jersey $412M AUM 15.82% 1-Year Est. Return
THCM
Taylor Hoffman Capital Management Richmond, Virginia $412M AUM 57.16% 1-Year Est. Return
PA
Prism Advisors Studio City, California $412M AUM 20.58% 1-Year Est. Return

EntryPoint Capital's Q2 2024 Portfolio in Review

As of Q2 2024, EntryPoint Capital held 1,960 positions worth $215M, up 93% from $112M the previous quarter. Its ten largest holdings account for 3.3% of the portfolio.

EntryPoint Capital deployed $114M of net new capital in Q2 2024, opening 575 new positions and adding to 592 existing holdings. Its largest new stake was EyePoint Inc: 58,291 shares worth $507K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Oscar Health, an estimated $327K trimmed.

  • EntryPoint Capital's largest Q2 2024 buy was EyePoint Inc: 58,291 shares worth $507K.
  • EntryPoint Capital added most to Photronics in Q2 2024, an estimated $919K increase.
  • EntryPoint Capital's biggest Q2 2024 reduction was Oscar Health, cutting an estimated $327K.
  • EntryPoint Capital fully exited Sutro Biopharma in Q2 2024, selling an estimated $394K.
  • EntryPoint Capital's ten largest holdings make up 3.3% of its $215M portfolio in Q2 2024.
  • EntryPoint Capital opened 575 new positions and closed 602 in Q2 2024.
  • EntryPoint Capital's portfolio value rose 93% quarter-over-quarter to $215M.

Based on EntryPoint Capital's 13F filing for Q2 2024, filed 13 Aug 2024.